Photo of Dickran Kazandjian from umiamihealth.org
Sep 3, 2023, 05:14
Dickran (Diko) Kazandjian: MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.
Dickran (Diko) Kazandjian, a Professor of Medicine at the Sylvester Comprehensive Cancer Center and a Board Member of OncoDaily, shared on X/Twitter:
“MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Multiple Myeloma. Importantly, MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.”
For the original article click here.
For the editorial click here.
Source: Diko Kazandjian/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53
Apr 1, 2025, 11:51